COMMUNIQUÉS West-GlobeNewswire

Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
15/04/2019
Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019 Anticipates Launching New IXINITY 3,000 IU Assay Mid-2019 Advances Dosing in Additional Cohorts in APVO436 and APVO210 Clinical Programs On [...]
Auris Medical Receives Positive Nasdaq Listing Determination
15/04/2019
Hamilton, Bermuda, April 15, 2019 (GLOBE NEWSWIRE) -- Hamilton, Bermuda, April 15, 2019 – Auris Medical Holding Ltd. (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important [...]
Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
15/04/2019
- Clinical Hold until Additional CMC Information is Reviewed by FDA - - Independent DMC Review of Safety Data from First Cohort of Six Patients with No SAEs or DLTs - - Adverum Plans to Present 24-Week Data from First [...]
Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles
15/04/2019
RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME TM , a first of its kind solution [...]
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
15/04/2019
Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy Winslow as President for [...]
Immuron sales surge by 66% in the Third Quarter of FY19
15/04/2019
Key Highlights: Immuron achieved 66% YoY growth in worldwide sales for the third quarter of FY19, ending March 31, 2019. In Australia Q3 sales of Travelan® surged ahead, growing 73% YoY. In the US Q3 sales of Travelan® [...]
Biofongicide Regalia® Maxx de Marrone Bio Innovations est approuvé dans la production du cannabis au Canada.
15/04/2019
Marrone Bio Innovations a sélectionné un nouveau distributeur canadien pour renforcer sa présence dans le marché croissant du cannabis. DAVIS, Californie, 15 avr. 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. ( [...]
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results
15/04/2019
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
InMode Launches AccuTite, Newest Minimally Invasive Technology
15/04/2019
LAKE FOREST, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- InMode Ltd., a leading global provider of innovative, energy-based, minimally invasive solutions, introduces AccuTite, the smallest Radio-Frequency Assisted [...]
Cassava Sciences Completes Patient Enrollment for a Phase 2a Study in Patients with Alzheimer’s Disease
15/04/2019
AUSTIN, Texas, April 15, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, announced the completion of patient enrollment in a clinical study evaluating the safety [...]
Hemostemix Announces Convertible Debenture Financing
15/04/2019
NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: [...]
Golden Leaf Holdings Corporate Update
15/04/2019
TORONTO, April 15, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis company built around recognized brands for the wellness and recreational markets [...]
Wildflower and Its Role in Burgeoning CBD Market Featured in NetworkNewsWire Publication
15/04/2019
NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted [...]
Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
15/04/2019
Phase 3 study of AG10 in patients with ATTR-CM (ATTRIBUTE-CM) underway SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), today reported its financial results for the [...]
INSYS Therapeutics Implements Leadership Changes
15/04/2019
Andrew G. Long Appointed Chief Executive Officer PHOENIX, April 15, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical [...]
Ceapro Inc. Announces Positive Key Findings from Three Oral Presentations Given at European Meeting on Supercritical Fluids
15/04/2019
Research findings from collaboration between University of Alberta and Ceapro on PGX Technology further confirm versatility of PGX Technology and the potential as a platform for delivery systems EDMONTON, Alberta, April [...]
iCAD Wins Three-System Public Bid with Leading Cancer Organization in Spain, Expanding European Access to Innovative Cancer Treatments with the Xoft System
15/04/2019
Two additional Spanish centers announce adoption of the Xoft System, totaling seven installations across four major regions in Spain Internationally-recognized institutions strengthen portfolio of comprehensive cancer [...]
SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock™ Novel Spinopelvic Fixation Technology
15/04/2019
SANTA CLARA, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley based medical device company dedicated to solving musculoskeletal disorders of the spinopelvic anatomy, today [...]
TYME Announces USAN Approval of Generic Name “Racemetyrosine” for SM-88
15/04/2019
TYME to Initiate Pivotal Trials for SM-88 in Patients with Metastatic Pancreatic Cancer NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing [...]

Pages